Paper3014348
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy.
Kunkel LM and 76 others. Nature, 1986. Cited by 435 papers, by iCite.
Cite this record
ConductScience Library. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Papers, record 3014348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3014348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosome Deletion | Major topic |
| DNA | Major topic |
| Deoxyribonucleases, Type II Site-Specific | Major topic |
| Muscular Dystrophies | Major topic |
| Chromosome Mapping | |
| DNA Restriction Enzymes | |
| Deoxyribonuclease EcoRI | |
| Electrophoresis, Polyacrylamide Gel | |
| Genes | |
| Humans | |
| Male | |
| Pedigree |
Source PubMed
Cited by141
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 435 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42846216 | X;7 Translocation at p21.1 and q31.31 Disrupting DMD: A Multiomics Study of a Male Dystrophinopathy Case. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42846216 | PubMed |
| 42840036 | From molecular correction to functional rescue: delivery, tissue state, and immunobiology as the principal constraints on dystrophin-restoring therapy in Duchenne muscular dystrophy. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42840036 | PubMed |
| 42001993 | Phospho-mimic βIII-tubulin rescues microtubule and cardiac defects in Duchenne muscular dystrophy mice. | J Mol Cell Cardiol | 2026 | https://conductscience.org/library/papers/42001993 | PubMed |
| 41193203 | Exploring the evidence for the use of protein biomarkers of muscular damage and disease progression in Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis protocol. | BMJ Open | 2025 | https://conductscience.org/library/papers/41193203 | PubMed |
| 40493400 | Expression of full-length dystrophin reverses muscular dystrophy defects in young and old mdx4cv mice. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40493400 | PubMed |
| 40181545 | The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy. | Mol Ther | 2025 | https://conductscience.org/library/papers/40181545 | PubMed |
| 39020181 | Split intein-mediated protein trans-splicing to express large dystrophins. | Nature | 2024 | https://conductscience.org/library/papers/39020181 | PubMed |
| 38363616 | Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease. | J Neuromuscul Dis | 2024 | https://conductscience.org/library/papers/38363616 | PubMed |
| 38047063 | Uncovering the true features of dystrophin gene rearrangement and improving the molecular diagnosis of Duchenne and Becker muscular dystrophies. | iScience | 2023 | https://conductscience.org/library/papers/38047063 | PubMed |
| 36918517 | Dystrophin Short Product, Dp71, Interacts with AQP4 and Kir4.1 Channels in the Mouse Cerebellar Glial Cells in Contrast to Dp427 at Inhibitory Postsynapses in the Purkinje Neurons. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/36918517 | PubMed |
| 36891137 | Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression. | Front Physiol | 2023 | https://conductscience.org/library/papers/36891137 | PubMed |
| 36873982 | Vascular therapy for Duchenne muscular dystrophy (DMD). | Fac Rev | 2023 | https://conductscience.org/library/papers/36873982 | PubMed |
| 36282542 | Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees. | Hum Mol Genet | 2023 | https://conductscience.org/library/papers/36282542 | PubMed |
| 35098363 | Generation of dystrophin short product-specific tag-insertion mouse: distinct Dp71 glycoprotein complexes at inhibitory postsynapse and glia limitans. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35098363 | PubMed |
| 34575126 | Dystrophin Dp71 Subisoforms Localize to the Mitochondria of Human Cells. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34575126 | PubMed |
| 34553265 | Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy. | Pflugers Arch | 2021 | https://conductscience.org/library/papers/34553265 | PubMed |
| 33150975 | Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathy. | Muscle Nerve | 2021 | https://conductscience.org/library/papers/33150975 | PubMed |
| 32958875 | Implications of germline copy-number variations in psychiatric disorders: review of large-scale genetic studies. | J Hum Genet | 2021 | https://conductscience.org/library/papers/32958875 | PubMed |
| 32608079 | The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene. | FEBS J | 2020 | https://conductscience.org/library/papers/32608079 | PubMed |
| 32034254 | High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy. | Sci Rep | 2020 | https://conductscience.org/library/papers/32034254 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3014348
GET https://conductscience.org/api/papers/v1/3014348/authors?page=2